DE3850002D1 - Stabilisierung von Deferoxamin für die Chelatbildung mit freien Ionen in physiologischem Serum. - Google Patents

Stabilisierung von Deferoxamin für die Chelatbildung mit freien Ionen in physiologischem Serum.

Info

Publication number
DE3850002D1
DE3850002D1 DE3850002T DE3850002T DE3850002D1 DE 3850002 D1 DE3850002 D1 DE 3850002D1 DE 3850002 T DE3850002 T DE 3850002T DE 3850002 T DE3850002 T DE 3850002T DE 3850002 D1 DE3850002 D1 DE 3850002D1
Authority
DE
Germany
Prior art keywords
deferoxamine
chelation
stabilization
free ions
physiological serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3850002T
Other languages
English (en)
Other versions
DE3850002T2 (de
Inventor
Bo Erik Hedlund
Samuel S Panter
Philip Eric Hallaway
John W Eaton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOMED FRONTIERS Inc
Original Assignee
BIOMED FRONTIERS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOMED FRONTIERS Inc filed Critical BIOMED FRONTIERS Inc
Publication of DE3850002D1 publication Critical patent/DE3850002D1/de
Application granted granted Critical
Publication of DE3850002T2 publication Critical patent/DE3850002T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
DE3850002T 1987-08-20 1988-07-29 Stabilisierung von Deferoxamin für die Chelatbildung mit freien Ionen in physiologischem Serum. Expired - Fee Related DE3850002T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/087,631 US4863964A (en) 1985-07-02 1987-08-20 Method for the stabilization of deferoxamine to chelate free ions in physiological fluid

Publications (2)

Publication Number Publication Date
DE3850002D1 true DE3850002D1 (de) 1994-07-14
DE3850002T2 DE3850002T2 (de) 1994-10-20

Family

ID=22206331

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3850002T Expired - Fee Related DE3850002T2 (de) 1987-08-20 1988-07-29 Stabilisierung von Deferoxamin für die Chelatbildung mit freien Ionen in physiologischem Serum.

Country Status (3)

Country Link
US (1) US4863964A (de)
EP (1) EP0304183B1 (de)
DE (1) DE3850002T2 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217998A (en) * 1985-07-02 1993-06-08 Biomedical Frontiers, Inc. Composition for the stabilization of deferoxamine to chelate free ions in physiological fluid
US5707604A (en) * 1986-11-18 1998-01-13 Access Pharmaceuticals, Inc. Vivo agents comprising metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles
US5672334A (en) * 1991-01-16 1997-09-30 Access Pharmaceuticals, Inc. Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans
GB8710598D0 (en) * 1987-05-05 1987-06-10 Star Medical Diagnostics Ltd Hemoglobin based blood substitute
US5189146A (en) * 1987-05-05 1993-02-23 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Pasteurizable, freeze-driable hemoglobin-based blood substitute
CA2084073A1 (en) * 1990-03-30 1991-10-01 Bo Erik Hedlund Fluid resuscitation
EP0523037A4 (en) * 1990-03-30 1993-07-28 Biomedical Frontiers, Inc. Fluid resuscitation
US5416078A (en) * 1990-03-30 1995-05-16 Biomedical Frontiers, Inc. Fluid resuscitation
CA2094028A1 (en) * 1990-10-16 1992-04-17 Bo E. Hedlund Polymer-deferoxamine-ferric iron adducts for use in magnetic resonance imaging
US5268165A (en) * 1990-10-16 1993-12-07 Biomedical Frontiers, Inc. Polymer-deferoxamine-ferric iron adducts for use in magnetic resonance imaging
CA2137563C (en) * 1992-06-08 2005-06-28 Thomas B. Ryder Preparation of nucleic acid from mononuclear cells
DE4230513C1 (de) * 1992-09-11 1994-03-31 Fresenius Ag Vorrichtung zur Entfernung von Aluminiumionen aus Blut und Lösung zur Verwendung in der Vorrichtung
HU213165B (en) * 1993-05-11 1997-02-28 Bot Process to prepare biopolymers with detoxicating activity
TW274630B (de) * 1994-01-28 1996-04-21 Wako Zunyaku Kogyo Kk
US5811510A (en) * 1995-04-14 1998-09-22 General Hospital Corporation Biodegradable polyacetal polymers and methods for their formation and use
US6087345A (en) * 1995-05-31 2000-07-11 Meiji Seika Kaisha, Ltd. Material inhibiting lipid peroxide-increase
US6106866A (en) * 1995-07-31 2000-08-22 Access Pharmaceuticals, Inc. In vivo agents comprising cationic drugs, peptides and metal chelators with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles, including tumor sites
US5723131A (en) 1995-12-28 1998-03-03 Johnson & Johnson Vision Products, Inc. Contact lens containing a leachable absorbed material
US5770637A (en) * 1996-05-01 1998-06-23 Johnson & Johnson Vision Products, Inc. Anti-bacterial, UV absorbable, tinted, metal-chelating polymers
ES2123432B1 (es) * 1996-10-15 1999-10-01 Syntex Sa Aductos de complejos polihidroxilados de hierro trivalente con albumina soluble, metodo de obtencion y preparaciones farmaceuticas y dieteticas que los contienen.
US6780852B2 (en) 1997-12-09 2004-08-24 Bo E. Hedlund Modified polysaccharides exhibiting altered biological recognition
AU761784B2 (en) * 1997-12-09 2003-06-12 Biomedical Frontiers, Inc. Modified polysaccharides exhibiting altered biological recognition
US20030236224A1 (en) * 1997-12-09 2003-12-25 Hedlund Bo E. Modified polysaccharides exhibiting altered biological recognition
DE60018925T2 (de) * 1999-05-27 2006-04-13 Pharmacia Corp.(N.D.Ges.D.Staates Delaware) Biomaterialien, modifiziert mit superoxid-dismutase imitatoren
DE10112825A1 (de) 2001-03-16 2002-10-02 Fresenius Kabi De Gmbh HESylierung von Wirkstoffen in wässriger Lösung
DE10209821A1 (de) * 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung von Proteinen an ein modifiziertes Polysaccharid
DE10209822A1 (de) * 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid
DE10242076A1 (de) * 2002-09-11 2004-03-25 Fresenius Kabi Deutschland Gmbh HAS-Allergen-Konjugate
CN100348618C (zh) * 2002-09-11 2007-11-14 弗雷泽纽斯卡比德国有限公司 生产羟烷基淀粉衍生物的方法
AU2003273413A1 (en) * 2002-10-08 2004-05-04 Fresenius Kabi Deutschland Gmbh Pharmaceutically active oligosaccharide conjugates
AU2003299590B8 (en) * 2002-12-09 2010-04-08 Abraxis Bioscience, Llc Compositions and methods of delivery of pharmacological agents
WO2005014655A2 (en) * 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
WO2005014024A2 (en) * 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of a polymer and a protein linked by an oxime linking group
SG145746A1 (en) * 2003-08-08 2008-09-29 Fresenius Kabi De Gmbh Conjugates of hydroxyalkyl starch and g-csf
WO2005092928A1 (en) 2004-03-11 2005-10-06 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination
TW200603818A (en) * 2004-03-11 2006-02-01 Fresenius Kabi De Gmbh Conjugates of hydroxyethyl starch and erythropoietin
CA2598528A1 (en) * 2005-03-11 2006-09-14 Fresenius Kabi Deutschland Gmbh Production of bioactive glycoproteins from inactive starting material
US8454934B2 (en) * 2006-05-25 2013-06-04 Canadian Blood Services High molecular weight chelation structure
EP2070950A1 (de) 2007-12-14 2009-06-17 Fresenius Kabi Deutschland GmbH Hydroxyalkylstärkederivate und deren Herstellungsverfahren
WO2010147621A1 (en) * 2009-06-16 2010-12-23 The Trustees Of Columbia University In The City Of New York Methods for ameliorating adverse effects associated with transfusion of aged red blood cells

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3158552A (en) * 1961-06-29 1964-11-24 Ciba Geigy Corp Process for the manufacture of desferrioxamines
US4024073A (en) * 1972-01-08 1977-05-17 Toray Industries, Inc. Hydrogel and production thereof
IL42204A (en) * 1972-05-08 1976-09-30 Solco Basel Ag Process and apparatus for the manufacture of injectable radionuclide preparations
US3957435A (en) * 1974-12-12 1976-05-18 Miles Laboratories, Inc. Passive hemagglutination test method and composition for use therein
JPS56125317A (en) * 1980-03-08 1981-10-01 Nippon Mejifuijitsukusu Kk Stable radioactive diagnosticum with radioactive metallic mark
NZ201010A (en) * 1981-06-19 1986-02-21 Ciba Geigy Ag The treatment of inflammation diseases using desferrioxamine
IL65131A0 (en) * 1982-02-28 1982-04-30 Yeda Res & Dev Process for the production of agarose-polyaldehyde beads and their biological applications
US4613616A (en) * 1984-07-20 1986-09-23 Research Corporation Polymeric iron chelators
EP0214101A3 (de) * 1985-09-03 1989-05-31 Ciba-Geigy Ag Verwendung von Eisen(III)-Chelatoren vom Typ Desferrioxamin B und Desferriferrithiocin zur Behandlung von Malaria

Also Published As

Publication number Publication date
US4863964A (en) 1989-09-05
EP0304183A1 (de) 1989-02-22
EP0304183B1 (de) 1994-06-08
DE3850002T2 (de) 1994-10-20

Similar Documents

Publication Publication Date Title
DE3850002T2 (de) Stabilisierung von Deferoxamin für die Chelatbildung mit freien Ionen in physiologischem Serum.
CA1024868A (en) Reagent and method for determining leukocytes and hemoglobin in the blood
DE3853057D1 (de) Entfernbare endoarterielle-Vorrichtung, bestimmt für die Reparatur von Ablösungen in arteriellen Wänden.
DE3578360D1 (de) Magnetischer niederprofilaufbau in welchem eine windung die andere traegt.
DE3689166D1 (de) Substanzquantifizierung in Tierkörpern.
NO885836D0 (no) Kvantitativ metode for bestemmelse av 1,4-dihydronikotinamid-adenin-dinukleotid i opploesning.
DE68924743D1 (de) Digitales Konzentrationsüberwachungsgerät von Silber-Ionen für die Ausfällung von Silber-Halogen-Emulsionen.
DE3854317D1 (de) Magnetische Karte.
FR2353060A1 (fr) Etalon de serum sanguin et procede de preparation
DE3884744D1 (de) Hämoglobinkomplexe.
IT8720800A0 (it) Composto attivo nella terapia carciovascolare.
ES257274Y (es) Tarjeta plastificable en frio perfeccionada
JPS5380496A (en) Block type polyamino acid and its manufacture
BR6701545U (pt) Disposicoes construtivas introduzidas em oculos
IT8720936A0 (it) Scheda di identificazione eprocedimento per la sua fabbricazione.
IL50944A (en) Assay method and kit for the quantitative determination of ahapten in aqueous solution
BR6701570U (pt) Disposicao introduzida em calcado
BR6500684U (pt) Disposicoes introduzidas em oculos
BR6401607U (pt) Disposicoes introduzidas em oculos
ES256365U (es) Forjado plano perfeccionado
BR6702072U (pt) Apresentacao em petisco
BR8702740A (pt) Processo de costura direta de solado em gaspea e solado usado no mesmo
IT8748399A0 (it) Portatessera con linguetta estraibile
BR6700242U (pt) Disposicoes introduzidas em peteca
IT8353876V0 (it) Ago per cucitura in genere

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee